The aim of the present study was to evaluate the effects of Lactobacillus rhamnosus GG (LGG; ATCC 53013) on growth performance and hepatotoxicity in calves fed a single dose of aflatoxin B 1 (AFB 1) and to investigate the absorption, distribution, and elimination of AFB 1 and the hydroxylated metabolite aflatoxin M 1 (AFM 1) in rumen fluid, blood, and excretions. Twentyfour male Holstein calves were blocked for body weight and age and were randomly assigned to 1 of 3 treatment groups: (1) untreated control, (2) treated with 4.80 mg of AFB 1 (AFB 1 only), or (3) treated with 1 × 10 10 cfu of LGG suspension and 4.80 mg of AFB 1 (AFB 1 plus LGG). The calves received LGG suspension in 50 mL of phosphate-buffered saline daily via oral administration for 14 d before and on the day they received a single oral dose of AFB 1. Body weight was recorded at the beginning of the study (before LGG administration), at the day of AFB 1 administration, and at the end of the trial. Rumen fluid, blood, urine, and feces samples were collected continuously for 96 h after AFB 1 administration. Average daily gain (ADG) and plasma biochemical parameters were analyzed, and concentrations of AFB 1 and AFM 1 in the samples were determined for monitoring excretion pattern and toxicokinetics. The results showed that ADG was lower in AFB 1-treated animals; LGG administration partially mitigated the decrease in ADG (0.85 ± 0.08 vs. 0.76 ± 0.18 kg of gain/d). The AFB 1 treatment increased plasma aspartate aminotransferase, alkaline phosphatase, and lactate dehydrogenase levels. Administration of LGG alleviated the AFB 1-induced increase in plasma enzymes activity. The excretion patterns of AFB 1 and AFM 1 were surprisingly regular; toxins were rapidly detected in all samples after a single oral dose of AFB 1 , and the peak of toxins concentrations was sequentially reached in rumen fluid, plasma, urine, and feces (except AFM 1 in rumen fluid), followed by an exponential decrease. The excretion curves showed that AFB 1 and AFM 1 concentrations were the highest in feces and urine, respectively. Administration of LGG decreased the concentrations of free AFB 1 and AFM 1 in rumen fluid and reduced the release of toxins into plasma and urine. Toxicokinetic parameters (except for the time of maximum concentration and the terminal half-life) were reduced by LGG administration. In conclusion, the absorption, distribution, and excretion of AFB 1 and AFM 1 were rapid in calves fed a single dose of AFB 1. Urine was the main route for the excretion of AFM 1 , and the clearance pattern from the peak of concentration was well fitted by exponential decreasing function. Administration of LGG reduced the absorption of AFB 1 in the gastrointestinal tract by increasing the excretion via the feces, thus alleviating the hepatotoxic effect of AFB 1 .
ABSTRACT. In this study, molecular markers were designed based on the sex determination genes ACS7 (A) and WIP1 (G) and the domain in the Fusarium oxysporum-resistant gene Fom-2 (F) in order to achieve selection of F. oxysporum-resistant gynoecious melon plants. Markers of A and F are cleaved amplified polymorphic sequences that distinguish alleles according to restriction analysis. Twenty F 1 and 1863 F 2 plants derived from the crosses between the gynoecious line WI998 and the Fusarium wilt-resistant line MR-1 were genotyped based on the markers. The results showed that the polymerase chain reaction and enzyme digestion results could be effectively used to identify plants with the AAggFF genotype in F 2 populations. In the F 2 population, 35 gynoecious wilt-resistant plants were selected by marker-assisted selection and were confirmed by disease infection assays, demonstrating that these markers can be used in breeding to select F. oxysporum-resistant gynoecious melon plants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.